Abstract:Background: Cardiometabolic disorders, notably primary hypertension and type 2 diabetes, present substantial global health challenges. The intricate interplay between metabolic and cardiovascular pathways has prompted extensive research into molecular mechanisms linking these conditions. The adipokine Retinol Binding Protein 4 (RBP4), initially recognized for retinol transport, has emerged as a potential biomarker in the network of metabolic and cardiovascular dysfunction. Recent studies implicate RBP4 in insulin resistance and its complications, including hypertension. This study explores RBP4 dynamics in patients with primary hypertension and type 2 diabetes, aiming to contribute valuable insights into diagnostic and therapeutic advancements in managing these interconnected disorders. Methods: This cross-sectional study, conducted over 2 years in a tertiary healthcare centre of North India, aimed to investigate the serum concentration of Retinol Binding Protein 4 (RBP4) in 119 participants diagnosed with primary hypertension and type 2 diabetes. Ethical guidelines were strictly followed, and comprehensive clinical assessments, including blood pressure measurements, were performed. RBP4 levels were quantified using an ELISA kit, alongside markers of insulin resistance. Statistical analyses, involving t-tests and correlation assessments, sought to unravel potential associations between RBP4, insulin resistance, and blood pressure parameters using SPSS 20.0. Results: The study comprised 61 healthy control (HC) participants and 58 individuals diagnosed with both essential hypertension and type 2 diabetes (EH+T2D). EH+T2D participants were on average older (45.71 ± 9.29 years vs. 40.34 ± 9.47 years, P = 0.002). Dyslipidemia prevalence was markedly higher in EH+T2D (72.4% vs. 11.4%, P < 0.0001), accompanied by disrupted lipid profiles. Serum RBP4 concentration was significantly elevated in EH+T2D (49.17 ± 19.37 mg/L, P < 0.0001), suggesting its potential role in the shared pathophysiology of primary hypertension and type 2 diabetes. Pearson's correlation analysis revealed associations between RBP4 levels, metabolic, and cardiovascular parameters, underscoring its potential as a link between these conditions. Conclusion: Elevated serum RBP4 levels suggest its potential as a novel biomarker in the shared pathophysiology of primary hypertension and type 2 diabetes. The correlation analysis highlights the intricate interplay between metabolic, lipid, and cardiovascular parameters, emphasizing the need for holistic interventions.

Serum Retinol-Binding Protein 4 Levels Are Elevated but Do Not Contribute to Insulin Resistance in Newly Diagnosed Chinese Hypertensive Patients

Increased Retinol-Free RBP4 Contributes to Insulin Resistance in Gestational Diabetes Mellitus

Serum retinal-binding protein 4 is positively related to insulin resistance in Chinese subjects with type 2 diabetes.

Significance of RBP4 in Patients with Gestational Diabetes Mellitus: a Case-Control Study of Han Chinese Women

Retinol-binding Protein-4 and Nonalcoholic Fatty Liver Disease

Serum Retinol‐binding Protein 4 is Associated with Insulin Secretion in Chinese People with Normal Glucose Tolerance

The Relationship Between Retinol-Binding Protein 4 Concentrations and Gestational Diabetes Mellitus in Chinese Women

Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people.

Serum Retinol Binding Protein 4 and Cardiovascular Disease

Association of Serum Retinol-Binding Protein 4 and Visceral Adiposity in Chinese Subjects with and Without Type 2 Diabetes

Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population

Change of Retinol Binding Protein-4 Concentrations in Patients with Type 2 Diabetes Mellitus and Its Relationship with Glucose and Lipid Metabolism

Serum retinol binding protein 4 in individuals with essential hypertension and type 2 diabetes: A cross-sectional study

Elevated retinol binding protein 4 induces apolipoprotein B production and associates with hypertriglyceridemia.

Elevated RBP4 Plasma Levels Were Associated with Diabetic Retinopathy in Type 2 Diabetes.

Association of Serum Retinol-Binding Protein 4 Levels and the Risk of Incident Type 2 Diabetes in Subjects With Prediabetes.

Relationship between Retinol-Binding Protein 4,obesity and insulin resistance

Change and Clinical Significance of Serum Retinal Binding Protein-4 Levels in Patients with Obesity and Type 2 Diabetes 1

Serum Retinol Binding Protein 4 and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

Serum Levels of RBP4 Might Not Be Determined by Diabetes Mellitus but by Kidney Function and Renal Replacement Therapy

Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional study